您要查找的是不是：
- Heparin lyase 肝素裂解酶
- Heparin is the treatment of choice. 肝素为首选的治疗剂。
- Human heparin sulphate protoglycans，HSPG Elisa ... 人硫酸肝素糖蛋白（HSPG）试剂盒；
- Heparin is not intended for intramuscular use. 肝素是不打算肌肉注射使用。
- The precision of new citrate lyase method has been testified. 2. 2.;柠檬酸碳酸氢盐透析液干粉是安全性可靠的。
- Heparin is the most widely used and reliable anticoagulant. 肝素为最广泛应用及最可靠的抗凝剂。
- To discuss the nursing maneuver of hemodialysis without heparin. 目的探讨无肝素血液透析的护理策略。
- Baxter accounts for about half the U.S. supply of heparin. 巴克斯证实大约一半肝磷脂由美国供应。
- Exceptio include phenytoin, theophylline, and heparin. 只有苯妥英、茶碱和肝素是例外。
- Exceptions include phenytoin, theophylline, and heparin. 只有苯妥英、茶碱和肝素是例外。
- The results implicates that the lyase domain of AphA existing in AphA(26-320). 维系细菌光敏色素A phA与色素自催化连接的裂合酶结构域位于A phA(26-320)包含的肽链之中。
- All cases received heparin and urokinase perioperatively. 围手术期抗凝治疗。
- The results suggest that heparin could interrupt AGE clearance... 低分子量肝素对AGE受体无封闭作用。
- Heparin-induced thrombocytopenia occurring after discontinuation of heparin. 肝素停药后发生的肝素相关性血小板减少。
- Serum phosphate levels were elevated throughout the heparin calcium therapy. 整个肝素钙治疗过程中，患者的血磷水平都升高。
- The penetration rates of MPS were between 6 and 50 times of those of heparin. MPS（多磺酸粘多糖）的透皮吸率是肝素的6－50倍。
- Conclusion Heparin could make PLT and MPV decreased, especially in UFH group. 结论肝素抗凝可致PLT及MPV下降,UFH尤其显著;
- This work provides important support for further research of the structure and functions of pectate lyase. 鉴于此，我们希望该研究工作能够为日后该类蛋白的结构和功能的进一步研究提供一点帮助。
- Objective: To discuss the nursing maneuver of hemodialysis without heparin. 目的探讨无肝素血液透析的护理策略。
- As new use of pectate lyase is continuously found, the enzyme has been a hot spot in scientific study. 随着果胶裂解酶的新用途的不断出现，因此该酶是近年国内外研究的热点课题。
